Document Detail


GPIIbIIIa inhibitors as adjunctive therapy in acute myocardial infarction.
MedLine Citation:
PMID:  10402105     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombolytic therapy has proved useful in the treatment of acute myocardial infarction but is frequently associated with limited vessel reperfusion and early reocclusion. Local platelet aggregation and activation play a role in these pathological processes, explaining the benefit of aspirin, a weak antiplatelet agent. Recent interest has turned to GPIIbIIIa antagonists, a class of potent inhibitors of platelet aggregation. Their concomitant use with fibrinolytics, in rescue and primary angioplasty for acute myocardial infarction treatment is explored. Efficacy and safety issues are addressed and the potential pivotal role of these agents in the treatment of acute myocardial infarction is discussed.
Authors:
M Salame; S Verheye; R More; S B King; N Chronos
Related Documents :
8328185 - Alteplase therapy in acute ischemic stroke: a danish pilot study.off.
8416765 - Inadvertent thrombolytic therapy for cardiovascular diseases masquerading as acute coro...
15943975 - Understanding the enzymology of fibrinolysis and improving thrombolytic therapy.
7625425 - Contemporary management of acute myocardial infarction.
15009875 - Arrhythmogenic right ventricular cardiomyopathy with left ventricular involvement and a...
11208235 - Mechanisms and management of paroxysmal supraventricular tachycardia.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of cardiology     Volume:  69     ISSN:  0167-5273     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-08-12     Completed Date:  1999-08-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  231-6     Citation Subset:  IM    
Affiliation:
Andreas Gruentzig Cardiovascular Center, Division of Cardiology, Emory University, Atlanta, GA 30322, USA. mysalame@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary
Drug Therapy, Combination
Humans
Myocardial Infarction / drug therapy*,  therapy
Platelet Aggregation / drug effects
Platelet Aggregation Inhibitors / therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
Randomized Controlled Trials as Topic
Thrombolytic Therapy*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Platelet Aggregation Inhibitors; 0/Platelet Glycoprotein GPIIb-IIIa Complex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The polar average reference effect: a bias in estimating the head surface integral in EEG recording.
Next Document:  Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patie...